Comparing the impact of psoriasis and atopic dermatitis on quality of life: co-calibration of the PSORIQoL and QoLIAD
- 377 Downloads
Disease-specific patient-reported outcome (PRO) measures are designed to be highly relevant to one disease. It is widely believed that comparisons of outcomes between patients with different diseases are only possible using generic measures. The present study employs a novel method of using Rasch analysis to co-calibrate scores from different disease-specific PRO measures, allowing scores to be compared across diseases.
Psoriasis patients (n = 146, mean age = 44.4, males = 50 %) completed the Psoriasis Quality of Life scale (PSORIQoL) and atopic dermatitis patients (n = 146, mean age = 45.5, males = 50 %) the Quality of Life in Atopic Dermatitis scale (QoLIAD). Both measures employ the needs-based model of QoL, and they share five common items—providing a link between assessments. The groups were analysed separately, and then combined to test fit to the Rasch model.
Both scales showed good fit to the Rasch model after minor adjustments (PSORIQoL: χ 2 p = 0.25; QoLIAD: χ 2 p = 0.51). For the combined dataset, one common item showing differential item functioning by disease was removed and fit to the Rasch model was achieved (χ 2 p = 0.08). The co-calibrated scale successfully distinguished between perceived severity groups (p < 0.001).
It is possible to co-calibrate scores on the PSORIQoL and QoLIAD. This is one of the first studies in health research to demonstrate how Rasch analysis can be used to make comparisons across diseases using different disease-specific measures. Such an approach maintains the greater relevance and, consequently, accuracy associated with disease-specific measurement.
KeywordsPsoriasis Atopic dermatitis PSORIQoL QoLIAD Rasch analysis Co-calibration Patient-reported outcomes Quality of life
The study was unfunded. We thank the patients who completed the PSORIQoL and QoLIAD, Professor CEM Griffiths from Salford Royal Hospital and the UK National Eczema Society.
- 3.Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-Item Short-Form Health Survey (SF-36). Medical Care, 30, 474–483.Google Scholar
- 7.McKenna, S. P., Cook, S. A., Whalley, D., Doward, L. C., Richards, H. L., Griffiths, C. E., et al. (2003). Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. British Journal of Dermatology, 149, 323–331.PubMedCrossRefGoogle Scholar
- 10.Nijsten, T. E., Meads, D. M., de Korte, J., Sampogna, F., Gelfand, J. M., Ongenae, K., et al. (2007). Cross-cultural inequivalence of dermatology-specific health related quality of life instruments in psoriasis patients. Journal of Investigative Dermatology, 127, 2315–2322.PubMedCrossRefGoogle Scholar
- 13.Prinsen, C. A., de Korte, J., Augustin, M., Sampogna, F., Salek, S. S., & Basra, M. K., et al. (2013). Measurement of health-related quality of life in dermatological research and practice: outcome of the EADV Taskforce on Quality of Life. Journal of the European Academy of Dermatology and Venereology, 27(10), 1195–203.Google Scholar
- 17.Potocka, A., Turczyn-Jabloñska, K., & Merecz, D. (2009). Psychological correlates of quality of life in dermatology patients: The role of mental health and self-acceptance. Acta Dermatovenerologica Alpina, Pannonica et Adriatica, 18(2), 53–58.Google Scholar
- 19.Quandt, S. A., Schulz, M. R., Vallejos, Q. M., Feldman, S. R., Verma, A., Fleischer, A. B., et al. (2008). The association of dermatologist-diagnosed and self-reported skin diseases with skin-related quality of life in Latino migrant farmworkers. International Journal of Dermatology, 47(3), 236–241.PubMedCrossRefGoogle Scholar
- 20.Papoutsaki, M., Chimenti, M. S., Costanzo, A., Talamonti, M., Zangrilli, A., Giunta, A., et al. (2007). Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics. Journal of the American Academy of Dermatology, 57(2), 269–275.PubMedCrossRefGoogle Scholar
- 22.Dallmeijer, A. J., de Groot, V., Roorda, L. D., Schepers, V. P., Lindeman, E., van den Berg, L. H., et al. (2007). Cross-diagnostic validity of the SF-36 physical functioning scale in patients with stroke, multiple sclerosis and amyotrophic lateral sclerosis: A study using Rasch analysis. Journal of Rehabilitation Medicine, 39(2), 163–169.PubMedCrossRefGoogle Scholar
- 23.Taylor, W. J., & McPherson, K. M. (2007). Using Rasch analysis to compare the psychometric properties of the short form 36 physical function score and the health assessment questionnaire disability index in patients with psoriatic arthritis and rheumatoid arthritis. Arthritis & Rheumatism (Arthritis Care & Research), 57(5), 723–729.CrossRefGoogle Scholar
- 24.Jenkinson, C., Fitzpatrick, R., Garratt, A., Peto, V., & Stewart-Brown, S. (2001). Can item response theory reduce patient burden when measuring health status in neurological disorders? Results from Rasch analysis of the SF-36 physical functioning scale (PF-10). Journal of Neurology, Neurosurgery and Psychiatry, 71, 220–224.PubMedCentralPubMedCrossRefGoogle Scholar
- 28.Dawson, J., Boller, I., Doll, H., Lavis, G., Sharp, R., Cooke, P., et al. (2012). Responsiveness of the Manchester-Oxford Foot Questionnaire (MOXFQ) compared with AOFAS, SF-36 and EQ-5D assessments following foot or ankle surgery. The Journal of Bone and Joint Surgery, 94(2), 215–221.PubMedCrossRefGoogle Scholar
- 32.Maslow, A. H. (1970). Motivation and personality (2nd ed.). New York: Harper & Row.Google Scholar
- 33.Max-Neef, M. A., Elizalde, A., & Hopenhayn, M. (1991). Human scale development: conception application and further reflections (p. 18). New York: Apex Press.Google Scholar
- 35.Rasch, G. (1960). (Reprinted 1980). Probabilistic Models for Some Intelligence and Attainment Tests.. Chicago: University of Chicago Press.Google Scholar
- 38.Holland, P. W., & Wainer, H. (Eds.). (1993). Differential item functioning. New Jersey: Lawrence Erlbaum Associates.Google Scholar
- 40.Andrich, D. (1988). Rasch models for measurement., Sage University paper series on Quality Application in the social sciences Sage Publications Inc: Newbury Park.Google Scholar
- 41.Andrich, D., Sheridan, B., & Luo, G. (2009). Interpretting RUMM2030 (4TH ed.). Perth: RUMM Laboratory Pty Ltd.Google Scholar
- 44.Crane, P. K., Narasimhalu, K., Gibbons, L. E., Mungas, D. M., Haneuse, S., Larson, E. B., et al. (2008). Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline. Journal of Clinical Epidemiology, 61(10), 1018–1027.PubMedCentralPubMedCrossRefGoogle Scholar
- 45.Chalkidou, K. & Anderson, G. (2009). Comparative effectiveness research: international experiences and implications for the United States. http://www.academyhealth.org/files/publications/CER_International_Experience_09%20(3).pdf September, 2013.
- 49.McKenna, S. P., Doughty, N., Meads, D. M., Doward, L. C., & Pepke-Zaba, J. (2006). The Cambridge pulmonary hypertension outcome review (CAMPHOR): A measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Quality of Life Research, 15(103–115), 54.Google Scholar
- 50.Haley, S. M., Ni, P., Lai, J. S., Tian, F., Coster, W. J., Jette, A. M., et al. (2011). Linking the activity measure for post acute care and the quality of life outcomes in neurological disorders. Archives of Physical Medicine and Rehabilitation, 92, S37–S43.PubMedCentralPubMedCrossRefGoogle Scholar
- 55.Angoff, W.H. Scales, norming, and equivalent scores. In R. L. Thorndike (Ed.), Education measurement (2nd ed., pp. 508–600). Washington, DC: American Council on Education.Google Scholar